[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2004, 30(3) 143-145 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
��Ѫ��ϸ����ֲ
Ƥ������
����
���������������
�¹��
��ɽ�
PubMed
Article by
Article by

��Ѫ��ϸ����ֲ�Ʒ���Ƥ���Ƶ�Ӧ��

�¹��, ��ɽ�

�㽭��ѧ�����ڶ�ҽԺƤ���� ���� 310009

ժҪ��

ϵͳ�Ժ���Ǵ���������ϵͳ��Ӳ��֢��ަ����ѿ�׺���м���ȶԻ���Σ�����������ѡ�������������Ѫ��ϸ����ֲ������ЩƤ��������ȡ��һ����Ч������Ѫ��ϸ����ֲ��Ƥ���Ƶ�Ӧ����״����������

�ؼ����� ��Ѫ��ϸ����ֲ   Ƥ������   ����  

Abstract:

Keywords:
�ո����� 2003-07-01 �޻�����  ����淢������  
DOI:
������Ŀ:

ͨѶ����:
���߼��:

�ο����ף�
[1] Amos TA, Gordon MY. Sources of human hematopoietic stem cells for transplantation-a review. Cell Transplant, 1995, 4:547-569.
[2] Sullivan KM, Furst DE. The evolving role of blood and marrow transplantation for the treatment of autoimmuue diseases. J Rheumatol Suppl, 1997, 48:1-4.
[3] Burt RK. BMT for severe autoimmune diseases: an idea whose time has Come. Oncology (Huntingt), 1997, 11:1001-1017.
[4] Marmont AM, van Lint MT, Gualandi F, et al. Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus, 1997,6:545-548.
[5] Traynor A, Burt RK. Haernatopoietic stem cell transplantation for active systemic lupus erythematosus. Rheumatology (Oxford), 1999,38:767-772.
[6] Wulffraat NM, Sanders EA, Kamphuis SS, et al. Prolonged remission without treatment after autologous stem cell transplantation for refractory ehillhood systemie lupus erythematosus. Arthritis Rheum, 2001,44:728-731.
[7] Traynor AE, Barr WG, Rosa RM, et al. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients. Arthritis Rhemm, 2002, 46:2917-2923.
[8] Martini A, Maccario R, Ravelli A. et al. Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis. Arthritis Rheum, 1999, 42:807-811.
[9] Binks M, Passweg JR, Furst D, et al. Phase 1/11 trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheun Dis, 2001, 60(6):577-584.
[10] Farge D, Marolleau JP, Zohar S, et al. Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase 1-11 study. Br J Haematol,2002, 119:726-739.
[11] Olavarria E, Chill F, Woolfbrd A, et al. T-cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvement. Br J Haematol,2001, 114:624-631.
[12] Burt RK, Guitart J, Traynor A, et al. Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor eftect. Bone Marrow Transplant, 2000, 25: 111-113.
[13] Masood N, Russell KJ, Olerud JE, et al. Induction of complete remission of advanced stage mycosis fungoides by allogeneic hematopoietic sten cell transplantation. J Am Acad Dermatol, 2002,47:140-145.
[14] Cooley HM, Snowden JA, Grigg AP, et al. Ontcome of rheumatoid arthritis and psoriasis following autologous stem cell transplantation for hematologic malignancy. Arthritis Rheum, 1997, 40:1712-1715.
[15] Slavin S, Nagler A, Varadi G, et al. Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol, 2000, 28:853-857.
[16] Chakrabarti S, Handa SK, Bryon RJ, et al. Will mixed ehimerism cure autoimmune diseases after a uonmyeloablative stem cell transplaut? Transplantation, 2001, 72:340-342.
[17] Chakraverty R, Rabin N, Peggs K, et al. Dermatomyositis and sarcoid-like reaction associated with multiple myeloma treated effectively by high-dose ehemotherapy and autulogous peripheral blood stem cell transplantation. Bone Marrow Transplant, 2001, 27: 1215-1217.
[18] Harvell JD, Hashem C, Williford PL, et al. Grover's-like disease in the setting of bone marrow transplantation and autologous peripheral blood stem cell infusion. Am J Dermatopathol, 1998, 20:179-184.
[19] Hensel M, Breitbart A, Ho AD. Autologous hematopoietic stem-cell transplantation for Beheet's disease with pulmonary involvement. N Engl J Med, 2001, 344:69.
[20] Waldmann V, Goldsehmidt H, Jackel A,et al. Transient complete remission of metastasized Merkel cell careinoma by high-dose polychemotherapy and autologous peripheral blood stem cell transplantation.Br J Dermatol, 2000, 143:837-839.
[21] Koizumi K, Sawada K, Nishio M, et al. Effective high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation in a patient with the aggressive form of cytophagic histiocytic panniculitis. Bone Marrow Transplant, 1997, 20:171-173.
�������������
1���γ���, �ƽ���.ӲƤ�����Ƶ��о���չ[J]. ����Ƥ���Բ�ѧ��־, 0,(): 271-273
2������, ������.������Ѫ��ϸ����ֲ����ϵͳ�Ժ���Ǵ�[J]. ����Ƥ���Բ�ѧ��־, 2003,29(3): 135-137
3���γ���, �ƽ���.ӲƤ�����Ƶ��о���չ[J]. ����Ƥ���Բ�ѧ��־, 0,(): 271-273
4���γ���, �ƽ���.ӲƤ�����Ƶ��о���չ[J]. ����Ƥ���Բ�ѧ��־, 2005,31(5): 271-273

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־